# A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA

> **NCT06049342** · PHASE1 · UNKNOWN · sponsor: **Nuwacell Biotechnologies Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** NCR100 injection

## Key facts

- **NCT ID:** NCT06049342
- **Lead sponsor:** Nuwacell Biotechnologies Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-25
- **Primary completion:** 2024-06
- **Final completion:** 2025-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-01-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049342, "A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06049342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*